ReviewMaterials today. Bio2026

Engineered artificial antigen-presenting cells for tumor immunotherapy: Design strategies, clinical applications, and translational challenges.

Haojie Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.